Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026Business Wire · Oct 14, 2026
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Has Average Price Target of $6.83Defense World · Oct 5, 2026
TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IPBusiness Wire · Sep 29, 2026
Maravai LifeSciences: The Post-COVID Reset Has Created An RNA Consumables FlywheelSeeking Alpha · Sep 2, 2026
Dimensional Fund Advisors LP Boosts Holdings in Maravai LifeSciences Holdings, Inc. $MRVIDefense World · Aug 13, 2026
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down – Here’s WhyDefense World · Aug 9, 2026Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody-based solutions for detecting impurities in biopharmaceutical manufacturing, and tools for monitoring protein expression across different tissue types. The company conducts its operations through two distinct segments: Nucleic Acid Production and Biologics Safety Testing.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.04 | -$0.02 | Beat |
| May 7, 2026 | -$0.05 | $0.01 | Beat |
| Feb 25, 2026 | -$0.07 | -$0.04 | Beat |
| Nov 6, 2025 | -$0.06 | -$0.08 | Miss |
| Aug 11, 2025 | -$0.06 | -$0.08 | Miss |
| May 12, 2025 | -$0.07 | -$0.08 | Miss |